Kane Biotech Inc. V.KNE

Buzz on the Bullboards: Volatility persists in the face of economic indicators

[Jonathon Brown]

Canada’s main stock index struggled and the NASDAQ hit a high, demonstrating a continued appetite for tech stocks amidst market volatility. read article.

[francoisl13]

Interesting to see that STEM Animal sales was picking up in Q1...that explain why they got a good offer from Dechra. The AGM meeting was interesting in a way that they confirmed everything that was

[PressRelease]

WINNIPEG, Manitoba, May 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its first quarter 2024 financial results. The Company previously announced on April 11, 2024 that it had reached an agreement in principle for the...read article.

[francoisl13]

As mentioned before, technical analysis for a microcap company is not as good as for larger companies but, it is interesting to note the following about KNE; 1. Short Term: The daily graph is in

[PressRelease]

WINNIPEG, Manitoba, May 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will...read article.

[francoisl13]

New Revyve data provided by Progenacare at the SAWC in Orlando. Here's an excerpt of their LinkedIN post; ''Poster Preview - CS-002 - Retrospective Case Series Evaluating the Effects

[PressRelease]

Named in Honour of the late Dr. Greg Schultz, Former Professor Emeritus at the University of Florida and Chief Science Officer of Kane Biotech WINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces its...read article.

[francoisl13]

Interesting piece of info found on the Progenacare LinkedIN page; ''We will also be presenting new clinical and scientific data on these products at the podium and in multiple posters, and

[francoisl13]

For those interesting by the wound care market (you should if you are following or have invested in KNE), please take 10-15 minutes ot read the Convatec 2023 annual report, there is a lot of

[francoisl13]

LinkedIN - take 2 Please have another look at KaneBiotech LinkedIN page. Pay attention to the latest post, It is interesting to note where (ie.: in front of what company stand) Mr Edwards took his

[francoisl13]

Please have a look at the latest video posted by Mr. Edwards on LinkedIN. He took a few minutes to update people on the latest happening with Aurena Labs in Sweden - the bag-on-valve developer - very

[francoisl13]

The April 18th presentation was, as far as I'm concern, a very good one put together by Mr. Edwards and Kane Biotech. It was complete, to the point and covering all aspects of the business that

[MirrorWorldMan]

These volumes haven't been seen for a while and cannot be ignored and I see it as a positive sign. I like to think it as some one taking an active interest and a substantial initial position

[Betteryear2]

WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern

[PressRelease]

What the sale of STEM Animal Health means for Kane going forward – Thursday April 18th, 2024 at 4:15pm Eastern Time WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024...read article.

[MirrorWorldMan]

1.71 M shares traded @ .12 at open today is interesting timing.